The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Association Between Prescription Co-Payment Amount and Compliance With Adjuvant Hormonal Therapy in Women With Early-Stage Breast Cancer
Open accessAbstract
Purpose: Noncompliance with adjuvant hormonal therapy among women with breast cancer is common. Little is known about the impact of financial factors, such as co-payments, on noncompliance. Patients and Methods: We conducted a retrospective cohort study by using the pharmacy and medical claims database at Medco Health Solutions. Women older than age 50 years who were taking aromatase inhibitors (AIs) for resected breast cancer with two or more mail-order prescriptions, from January 1, 2007, to December 31, 2008, were identified. Patients who were eligible for Medicare were analyzed separately. Nonpersistence was defined as a prescription supply gap of more than 45 days without subsequent refill. Nonadherence was defined as a medication possession ratio less than 80% of eligible days. Results: Of 8,110 women younger than age 65 years, 1,721 (21.1%) were nonpersistent and 863 (10.6%) were nonadherent. Among 14,050 women age 65 years or older, 3,476 (24.7%) were nonpersistent and 1,248 (8.9%) were nonadherent. In a multivariate analysis, nonpersistence (ever/never) in both age groups was associated with older age, having a non-oncologist write the prescription, and having a higher number of other prescriptions. Compared with a co-payment of less than $30, a co-payment of $30 to $89.99 for a 90-day prescription was associated with less persistence in women age 65 years or older (odds ratio [OR], 0.69; 95% CI, 0.62 to 0.75) but not among women younger than age 65, although a co-payment of more than $90 was associated with less persistence both in women younger than age 65 (OR, 0.82; 95% CI, 0.72 to 0.94) and those age 65 years or older (OR, 0.72; 95% CI, 0.65 to 0.80). Similar results were seen with nonadherence. Conclusion: We found that higher prescription co-payments were associated with both nonpersistence and nonadherence to AIs. This relationship was stronger in older women. Because noncompliance is associated with worse outcomes, future policy efforts should be directed toward interventions that would help patients with financial difficulties obtain life-saving medications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
Kirk, J., MacDonald, A., Lavender, P., Dean, J., & Rubin, G. (2017) · Biomedicine Hub · doi:10.1159/000480347 · Cited by 3,887
Update on Key Emerging Challenges in Cystic Fibrosis
Jennings, M. T., Riekert, K. A., & Boyle, M. P. (2014) · Medical Principles and Practice · doi:10.1159/000357646 · Cited by 3,648
Interventions for enhancing medication adherence
Nieuwlaat, R., Wilczynski, N., Navarro, T., Hobson, N., Jeffery, R., Keepanasseril, A., Agoritsas, T., Mistry, N., Iorio, A., Jack, S., et al. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000011.pub4 · Cited by 2,945
Methods for evaluation of medication adherence and persistence using automated databases
Andrade, S. E., Kahler, K. H., Frech, F., & Chan, K. A. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1230 · Cited by 1,079
Pop-Eleches, C., Thirumurthy, H., Habyarimana, J. P., Zivin, J. G., Goldstein, M. P., de Walque, D., MacKeen, L., Haberer, J., Kimaiyo, S., Sidle, J., et al. (2011) · AIDS · doi:10.1097/qad.0b013e32834380c1 · Cited by 982 · cited 2×
“One approach has been to use text messaging to provide reminders, which has been done with some success to increase adherence to medications for HIV.(45,46) There has also been Neugut et al”
MethodInfluentialGoldman, D. P., Joyce, G. F., & Zheng, Y. (2007) · JAMA · doi:10.1001/jama.298.1.61 · Cited by 874
Hershman, D. L., Shao, T., Kushi, L. H., Buono, D., Tsai, W. Y., Fehrenbacher, L., Kwan, M., Gomez, S. L., & Neugut, A. I. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1132-4 · Cited by 870 · cited 1×
“Similar results were observed for patients who were nonadherent.(7) Although some prior studies on predictors of adherence to hormonal therapy have focused on factors related to age, race, the specialty of the prescribing physician, and adverse effects, little attention has been paid to the cost of the medication itse…”
ResultSelf-citationHershman, D. L., Kushi, L. H., Shao, T., Buono, D., Kershenbaum, A., Tsai, W.-Y., Fehrenbacher, L., Lin Gomez, S., Miles, S., & Neugut, A. I. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.9655 · Cited by 828
Self-citationBurstein, H. J., Prestrud, A. A., Seidenfeld, J., Anderson, H., Buchholz, T. A., Davidson, N. E., Gelmon, K. E., Giordano, S. H., Hudis, C. A., Malin, J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.3756 · Cited by 796
Hess, L. M., Raebel, M. A., Conner, D. A., & Malone, D. C. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1h018 · Cited by 756
Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer
Partridge, A. H., Wang, P. S., Winer, E. P., & Avorn, J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.071 · Cited by 676
Noens, L., van Lierde, M.-A., De Bock, R., Verhoef, G., Zachée, P., Berneman, Z., Martiat, P., Mineur, P., Van Eygen, K., MacDonald, K., et al. (2009) · Blood · doi:10.1182/blood-2008-12-196543 · Cited by 616
Patient adherence and persistence with oral anticancer treatment
Ruddy, K., Mayer, E., & Partridge, A. (2009) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20004 · Cited by 569 · cited 1×
“This issue may become increasingly important as more oral antinoeplastic drugs come into use.(41) There is a large body of literature regarding interventions for increasing medication adherence.”
BackgroundGrunfeld, E., Levine, M. N., Julian, J. A., Coyle, D., Szechtman, B., Mirsky, D., Verma, S., Dent, S., Sawka, C., Pritchard, K. I., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.2235 · Cited by 540
Pharmacy Benefits and the Use of Drugs by the Chronically Ill
Goldman, D. P. (2004) · JAMA · doi:10.1001/jama.291.19.2344 · Cited by 530
Adherence to Initial Adjuvant Anastrozole Therapy Among Women With Early-Stage Breast Cancer
Partridge, A. H., LaFountain, A., Mayer, E., Taylor, B. S., Winer, E., & Asnis-Alibozek, A. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.5451 · Cited by 482
Thinking Outside the Pillbox — Medication Adherence as a Priority for Health Care Reform
Cutler, D. M., & Everett, W. (2010) · New England Journal of Medicine · doi:10.1056/nejmp1002305 · Cited by 459
Routine follow up of breast cancer in primary care: randomised trial
Grunfeld, E., Mant, D., Yudkin, P., Adewuyi-Dalton, R., Cole, D., Stewart, J., Fitzpatrick, R., & Vessey, M. (1996) · BMJ · doi:10.1136/bmj.313.7058.665 · Cited by 401
McCowan, C., Shearer, J., Donnan, P. T., Dewar, J. A., Crilly, M., Thompson, A. M., & Fahey, T. P. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604758 · Cited by 343
Adherence to tamoxifen over the five-year course
Lash, T. L., Fox, M. P., Westrup, J. L., Fink, A. K., & Silliman, R. A. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9193-0 · Cited by 320
Intentional and non-intentional non-adherence to medication amongst breast cancer patients
Atkins, L., & Fallowfield, L. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.03.004 · Cited by 300
Grunfeld, E., Fitzpatrick, R. M., Mant, D., Yudkin, P. L., Adewuyi-Dalton, R., Stewart, J., Cole, D., & Vessey, M. P. (1999) · Europe PMC (PubMed Central) · Cited by 292
Fink, A. K., Gurwitz, J., Rakowski, W., Guadagnoli, E., & Silliman, R. A. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.064 · Cited by 281
Early discontinuation of tamoxifen: A Lesson for oncologists
Barron, T. I., Connolly, R., Bennett, K., Feely, J., & Kennedy, M. J. (2007) · Cancer · doi:10.1002/cncr.22485 · Cited by 279
Darkow, T., Henk, H. J., Thomas, S. K., Feng, W., Baladi, J.-F., Goldberg, G. A., Hatfield, A., & Cortes, J. (2007) · PharmacoEconomics · doi:10.2165/00019053-200725060-00004 · Cited by 271
A test of financial incentives to improve warfarin adherence
Volpp, K. G., Loewenstein, G., Troxel, A. B., Doshi, J., Price, M., Laskin, M., & Kimmel, S. E. (2008) · BMC Health Services Research · doi:10.1186/1472-6963-8-272 · Cited by 262
Adherence beliefs among breast cancer patients taking tamoxifen
Grunfeld, E. A., Hunter, M. S., Sikka, P., & Mittal, S. (2005) · Patient Education and Counseling · doi:10.1016/j.pec.2004.10.005 · Cited by 245
Conn, V. S., Hafdahl, A. R., Cooper, P. S., Ruppar, T. M., Mehr, D. R., & Russell, C. L. (2009) · The Gerontologist · doi:10.1093/geront/gnp037 · Cited by 227
Adjuvant hormonal therapy use among insured, low-income women with breast cancer
Kimmick, G., Anderson, R., Camacho, F., Bhosle, M., Hwang, W., & Balkrishnan, R. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.2419 · Cited by 198
Harris, B. L., Stergachis, A., & Ried, L. D. (1990) · Medical Care · doi:10.1097/00005650-199010000-00005 · Cited by 188
Impact of a prescription copayment increase on lipid-lowering medication adherence in veterans
Doshi, J. A., Zhu, J., Lee, B. Y., Kimmel, S. E., & Volpp, K. G. (2009) · Circulation · doi:10.1161/circulationaha.108.783944 · Cited by 184
Pharmaceutical policies: effects of cap and co-payment on rational drug use
Austvoll-Dahlgren, A., Aaserud, M., Vist, G. E., Ramsay, C., Oxman, A. D., Sturm, H., Kösters, J. P., & Vernby, Å. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007017 · Cited by 164
Lu, C. Y., Ross‐Degnan, D., Soumerai, S. B., & Pearson, S. (2008) · BMC Health Services Research · doi:10.1186/1472-6963-8-75 · Cited by 162
Mortality Impact of Less-than-Standard Therapy in Older Breast Cancer Patients
Yood, M. U., Owusu, C., Buist, D. S. M., Geiger, A. M., Field, T. S., Thwin, S. S., Lash, T. L., Prout, M. N., Wei, F., Quinn, V. P., et al. (2008) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2007.07.015 · Cited by 155
Partridge, A. H., Archer, L. E., Kornblith, A. B., Gralow, J. R., Grenier, D., Perez, E. A., Wolff, A. C., Wang, X., Kastrissios, H., Berry, D. A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.4671 · Cited by 153
Improving compliance and persistence to adjuvant tamoxifen and aromatase inhibitor therapy
Hadji, P. (2009) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2009.02.001 · Cited by 152
Follow-up of breast cancer in primary care vs specialist care: results of an economic evaluation
Grunfeld, E., Gray, A. M., Mant, D., Yudkin, P. L., Adewuyi-Dalton, R., Coyle, D., Cole, D., Stewart, J., Fitzpatrick, R. M., & Vessey, M. P. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690197 · Cited by 149
P4P4P: An Agenda For Research On Pay-For-Performance For Patients
Volpp, K. G., Pauly, M. V., Loewenstein, G., & Bangsberg, D. (2009) · Health Affairs · doi:10.1377/hlthaff.28.1.206 · Cited by 136
Johnson, R. E., Goodman, M. J., Hornbrook, M. C., & Eldredge, M. B. (1997) · Medical Care · doi:10.1097/00005650-199711000-00004 · Cited by 112
Predictors of First-Fill Adherence for Patients With Hypertension
Shah, N. R., Hirsch, A. G., Zacker, C., Wood, G. C., Schoenthaler, A., Ogedegbe, G. G., & Stewart, W. F. (2009) · American Journal of Hypertension · doi:10.1038/ajh.2008.367 · Cited by 102
A review of interventions used to improve adherence to medication in older people
Banning, M. (2009) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2009.03.011 · Cited by 98
Insight into Barriers Against Optimal Adherence to Oral Hormonal Therapy in Women with Breast Cancer
Kirk, M. C., & Hudis, C. A. (2008) · Clinical Breast Cancer · doi:10.3816/cbc.2008.n.016 · Cited by 88
Fairman, K. A., Motheral, B. R., & Henderson, R. R. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)90099-3 · Cited by 75
Locker, G. Y., Mansel, R. E., Cella, D. F., Dobrez, D. G., Sorensen, S. V., Gandhi, S., & on behalf of the ATAC Trialists’ Group (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9483-6 · Cited by 74
A Two-way Messaging System to Enhance Antiretroviral Adherence
Dunbar, P. J., Madigan, D., Grohskopf, L. A., Debra Revere, A., Woodward, J., Minstrell, J., Frick, P. A., Simoni, J. M., & Hooton, T. M. (2003) · Journal of the American Medical Informatics Association · doi:10.1197/jamia.m1047 · Cited by 69
McHorney, C. A., & Gadkari, A. S. (2010) · Patient Preference and Adherence · doi:10.2147/ppa.s10603 · Cited by 58
Magai, C., Consedine, N. S., Adjei, B. A., Hershman, D. L., & Neugut, A. I. (2006) · Health Education & Behavior · doi:10.1177/1090198107303281 · Cited by 46
Self-citationThe effect of prescription size on acquisition of maintenance medications
Steiner, J. F., Robbins, L. J., Roth, S., & Hammond, W. S. (1993) · Journal of General Internal Medicine · doi:10.1007/bf02600143 · Cited by 38
Babazono, A., Miyazaki, M., Imatoh, T., Une, H., Yamamoto, E., Tsuda, T., Tanaka, K., & Tanihara, S. (2005) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462305050300 · Cited by 35
Hawwa, A. F., Millership, J. S., Collier, P. S., McCarthy, A., Dempsey, S., Cairns, C., & McElnay, J. C. (2009) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-009-0700-1 · Cited by 29
Cited by
Zafar, S. Y., Peppercorn, J. M., Schrag, D., Taylor, D. H., Goetzinger, A. M., Zhong, X., & Abernethy, A. P. (2013) · The Oncologist · doi:10.1634/theoncologist.2012-0279 · Cited by 1,130
de Souza, J. A., Yap, B. J., Wroblewski, K., Blinder, V., Araújo, F. S., Hlubocky, F. J., Nicholas, L. H., O'Connor, J. M., Brockstein, B., Ratain, M. J., et al. (2017) · Cancer · doi:10.1002/cncr.30369 · Cited by 917
Murphy, C. C., Bartholomew, L. K., Carpentier, M. Y., Bluethmann, S. M., & Vernon, S. W. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2114-5 · Cited by 708
“Few [28, 30, 44, 46] studies explicitly addressed external validity.”
The development of a financial toxicity patient‐reported outcome in cancer: The COST measure
de Souza, J. A., Yap, B. J., Hlubocky, F. J., Wroblewski, K., Ratain, M. J., Cella, D., & Daugherty, C. K. (2014) · Cancer · doi:10.1002/cncr.28814 · Cited by 685
Yabroff, K. R., Dowling, E. C., Guy, G. P., Banegas, M. P., Davidoff, A., Han, X., Virgo, K. S., McNeel, T. S., Chawla, N., Blanch-Hartigan, D., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.62.0468 · Cited by 541
Metadata
- Authors
- Neugut, A. I., Subar, M., Wilde, E. T., Stratton, S., Brouse, C. H., Hillyer, G. C., Grann, V. R., & Hershman, D. L.
- Venue
- Journal of Clinical Oncology
- Published
- 2011-06-20
- Volume
- 29
- Issue
- 18
- Pages
- 2534-2542
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2154835844
- Cited by
- 354
- References
- 52
- FWCI
- 15.58
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.